Anti-Recombinant-C9 antibody [RM1A80] (STJA0026751)

SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
STJA0026751
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit monoclonal anti-Recombinant-Complement Component C9 Cleaved Into-Complement Component C9a-Complement Component C9b for use in IHC, IP and WB in Human samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsIHC/IP/WB
HostRabbit
ReactivityHuman
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDRM1A80
IsotypeIgG
ConjugationUnconjugated
PurificationProtein A/G purified from cell culture supernatant
Dilution RangeIHC: 1:100-1:200, IP: 1:20-1:50, WB: 1:1000-1:2000
Formulation0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium Azide
Storage InstructionSuitable for storage at +4°C between 1-2 weeks. For longer term store at-20°C for up to 12 months.

Target Information

Gene SymbolC9
Gene ID735
Uniprot IDCO9_HUMAN

Additional Info

Post Translational Modifications Thrombin cleaves factor C9 to produce C9a and C9b. Phosphorylation sites are present in the extracellular medium. Initially, positions and connectivity of disulfide bonds were based on peptide sequencing done for the human protein. The crystal structures for the human and mouse proteins corrected the positions and connectivities of the disulfide bonds. The distance between Cys-57 and Cys-94 in the monomeric mouse protein precludes formation of a disulfide bond, contrary to what is seen in the structure of the human polymeric form of the protein (Probable).
Function Pore-forming component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis. The MAC is initiated by proteolytic cleavage of C5 into complement C5b in response to the classical, alternative, lectin and GZMK complement pathways. The complement pathways consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system. Constitutes the pore-forming subunit of the MAC complex: during MAC assembly, C9 associates with the C5b8 intermediate complex, and polymerizes to complete the pore.
Protein Name Complement Component C9 Cleaved Into - Complement Component C9a - Complement Component C9b
Database Links Reactome: R-HSA-166665
Reactome: R-HSA-977606
Cellular Localisation Secreted
Target Cell Membrane
Multi-Pass Membrane Protein
Secreted As Soluble Monomer
Oligomerizes At Target Membranes
Forming A Pre-Pore
A Conformation Change Then Leads To The Formation Of A 100 Angstrom Diameter Pore
Alternative Antibody Names Anti-Complement Component C9 Cleaved Into - Complement Component C9a - Complement Component C9b antibody
Anti-C9 antibody

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins